| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc. | Keiley Elizabeth M | General Counsel | Jul 07, 2022 | Option Exercise | $2.20 | 17,572 | 38,658 | 0 | Jul 11, 2022, 04:06 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Keiley Elizabeth M | General Counsel | Nov 02, 2021 | Option Exercise | $2.94 | 3,669 | 10,787 | 42,572 | Nov 03, 2021, 04:04 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Keiley Elizabeth M | General Counsel | Oct 19, 2021 | Sale | $3.19 | 3,759 | 11,991 | 46,241 | Oct 20, 2021, 04:08 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | SVP & General Counsel | Mar 04, 2019 | Sale | $17.00 | 4,100 | 69,712 | 26,928 | Mar 06, 2019, 04:30 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | SVP & General Counsel | Jan 01, 2019 | Option Exercise | $12.78 | 1,605 | 20,512 | 31,844 | Jan 03, 2019, 04:30 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | SVP & General Counsel | Jun 13, 2018 | Option Exercise | $14.41 | 2,500 | 36,025 | 32,633 | Jun 14, 2018, 04:39 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | Senior VP & General Counsel | Jan 01, 2018 | Option Exercise | $13.97 | 1,142 | 15,954 | 24,251 | Jan 03, 2018, 04:30 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | Senior VP & General Counsel | Jun 15, 2017 | Sale | $15.01 | 4,085 | 61,305 | 25,393 | Jun 16, 2017, 04:32 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | Senior VP & General Counsel | Jun 09, 2017 | Option Exercise | $14.63 | 1,136 | 16,620 | 29,478 | Jun 13, 2017, 04:31 PM | |
| OXFD | Oxford Immunotec Global PLC | Keiley Elizabeth M | Senior VP & General Counsel | Mar 20, 2017 | Option Exercise | $4.03 | 14,185 | 57,210 | 30,614 | Mar 22, 2017, 04:59 PM |
Menu